Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged population. - Mercuri FA; Zhuang A; McQuilten HA; Jarnicki A; O'Donoghue R; O'Brien C; Ciccotosto GD; Zhang P; Demaison C; White S; West NP; Tal-Singer R; et al. (ERJ open research, 2025)